ELDERPHARM

The Exchange has sought clarification from the Company with respect to news item captioned "Elder Pharma files for Insolvency". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to

The Exchange has sought clarification from Elder Pharmaceuticals Limited with respect to recent news item captioned ''Elder Pharma, embroiled in bribery case, is among the biggest defaulters and the Ministry is doing nothing''. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this a

Elder Pharmaceuticals Limited has informed the Exchange vide letter dated October 12, 2015 regarding Clarification on various reports in News Papers.

The Exchange has sought clarification from Elder Pharmaceuticals Limited with respect to recent news item captioned Elder Pharma to sell assets to clear debt . The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has submitted their response.

The Exchange has sought clarification from Elder Pharmaceuticals Limited, with respect to recent news item captioned "Elder Pharma to sell assets to clear debt". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.

Significant price movement has been observed in Elder Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. The Company has submitted its clarification.

Elder Pharmaceuticals Limited has informed the Exchange regarding clarification on news item captioned "Elder Pharma got Rs. 2000 Cr by liquidating assets?". The Company has clarified that "The article is completely false and misleading and maligns company reputation by alleging money laundering by the management. This article is grossly defamatory and calculated to lower the standing and image of Elder Pharmaceuticals Ltd in the market. The said Article is thoroughly defamatory and published with malafide intentions with a view to hamper any effort made by the Company to revive and pay. Elder

Price movement : Significant price movement has been observed in Elder Pharmaceuticals Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "The Company is not aware about the reason for increase in price of share of the Company. The Company has neither proposed nor is contemplating any acquisition or merger or issue of fresh shares, or otherwise, that has led

Elder Pharmaceuticals Limited has informed the Exchange regarding "News reports in various media attributed to Press Trust Of India (PTI)".

The Exchange had sought clarification from Elder Pharmaceuticals Limited with respect to a news item captioned "Elder Pharma in revamp mode". The Company has clarified that "the Company has informed the Exchange on December 13,2013 about the sale of its formulation business in India and Nepal to Torrent Pharmaceuticals Limited. Post this deal, the Company's overall strategy is to focus on its remaining brands inclusive Eldervit and Somazina and position itself further in the growing neutraceuticals segment by launching more products of its own. Also the Company is also planning to concentrate

Elder Pharmaceuticals Limited has informed the Exchange vide letter dated November 22, 2013 regarding Clarification / Confirmation on news item spearing in the newapaper.

Elder Pharmaceuticals Limited has given clarification to the Exchange regarding the news item that appeared on November 01, 2013. "This refers to the news item that appeared in the Economic Times, Mumbai Edition on Friday the 1st November 2013. It was reported with the headline Elder Pharma Defaults on Rs. 261 cr Interest Payment on Debentures. While the Company has defaulted in interest payment on Debentures the fact is that the default is only to the tune of Rs. 10 crores and not Rs. 261 crores as reported. The error in reporting was corrected by Economic Times, Mumbai Edition on Thursday t

News Verification : The media had reports that Elder Pharmaceuticals Limited is in process to sell its domestic formulation business.. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "As informed earlier, at this stage the company does not have any definite proposal for sale of its domestic formulations business. The Company has been looking for opportunities of o

News Verification : The media had reports that the Promoters are in the process to sell stake in Elder Pharmaceuticals Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated,"As far as the Company is aware, there is no proposal of the promoters to sell the shares in the Company. The Company is constantly looking to add value to the shareholders and keeps conside

Spurt in Volume : Substantial increase in trading volumes have been observed in Elder Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "In the recent past there has not been any development in the Company or any information/announcement (including pending announcement) which in our opinion may have a bearing on the price/volume behavior in t

Elder Pharmaceuticals Limited has informed the Exchange that with reference to the news item "Elder Pharma weighs sale of nutrition business" appearing on various media websites, the Company hereby clarify that the Company has no intentions to sell any business nor is in any discussion with any party. The Company's Joint Managing Director has already denied in the said news item that the Company was looking to sell any Business.

Elder Pharmaceuticals Limited has informed the Exchange with reference to the news item appearing in the business section of a newspaper dated February 11, 2010 under the title "Elder Pharma Eyes Buyouts in Africa, Asia" that: "The news mentioned under the title is baseless and Mr. Alok Saxena did not speak to anybody on the contents mentioned under the above title".

Elder Pharmaceuticals Limited has informed the Exchange with reference to the news items that has appeared in the newspaper on January 15, 2010 regarding the Company. The Company wants to clarify that "Our Company through its Dubai subsidiary had entered into a joint venture in Ghana. However, for the reasons mentioned therein the same has been terminated. Through the said Dubai subsidiary the Company has established a Company under the laws of Bulgaria in which it owns 61 % stake. The said step down subsidiary has acquired Biomeda group companies in Bulgaria which are wholly owned by it".

News Verification : The media had reports that Elder Pharmaceuticals Limited is in final stages of acquiring a medium scale generic company in UK. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "As of now there are no plans of acquiring any Company in UK. However, in future whenever there is any plan, we will inform the Exchange accordingly."

News Verification : The media had reports that Elder Pharmaceuticals Limited may acquire 60% stake in Ghana-based Wincom Pharmaceuticals. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "We would like to inform you that the possibilities of the Joint Venture is being explored for quite some time and this was reported in the Directors Report for th

Clarification of News : The press had reports that Elder Pharmaceuticals Limited is setting up two formulations plants - one in Uttranchal and one in Himachal Pradesh. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "It is true that the Company plans to set up two formulation plants in Uttranchal and Himachal Pradesh and one of them is in the adva

Clarification of News : The media had reports that Elder Pharmaceuticals Limited has won outsourcing order from Iceland's Actavis. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "These are only rumours and the Company has not finalized anything with the said party."

News Verification : The press had reports that Elder Pharmaceuticals Limited is considering merging its group company Elder Projects with itself. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "Although we have long term plans of restructuring, definitive plans thereof have not yet been worked out. As and when the same are worked out and put bef

Clarification of News : The press had reports on January 08, 2005 that MNC Eli Lilly India has struck a deal to sell its anti-infective drug Tobraneg to Elder Pharmaceuticals Limited. The Exchange, in order to verify the accuracy or otherwise of the information reported in the press and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Elder Pharmaceuticals Limited has vide its letter inter-alia stated, "It is true that we have struck a deal with Eli Lilly and Company of USA for purchase of their brand "TOBRANEG" in In